The impact of side effects on hypertension management: A Japanese survey

Clinical Therapeutics

Volumn 19, Issue 6, 1997, Pages 1458-1469

  Toyoshima, Hideaki ^a   Takahashi, Kihito ^b   Akera, Tai ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antihypertensive drugs; Compliance; Hypertension; Side effects

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANOREXIA; ANTIHYPERTENSIVE THERAPY; COUGHING; DRUG USE; EDEMA; GYNECOMASTIA; HEADACHE; HUMAN; HYPERTENSION; IMPOTENCE; JAPAN; PATIENT COMPLIANCE; POLLAKISURIA; REVIEW; VERTIGO;

EID: 0031418063     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80019-7     Document Type: Note

References (19)

1. 1992 National Prevalence Survey of Circulatory Disorders. Tokyo, Japan: Ministry of Health and Welfare (KOSEISYO); 1994:36-42. In Japanese.
2. Masuyama Y, Arita M, Iimura O, et al. A multicenter double-blind comparison study of amlodipine and nicardipine-retard in patients with essential hypertension. Clin Eval. 1991;19:213-241. In Japanese.
3. Arakawa K, Iimura O, Yoshinaga K, et al. Clinical evaluation of felodipine (CGH 869) monotherapy in essential hypertension: Double-blind comparative study with nifedipine (Adalat® L). J Clin Ther Med. 1992;8:2659-2691. In Japanese.
4. Ishii M, Omae T, Matsuoka H, et al. A multicenter double-blind comparison study of FRC-8653 (cilnidipine) and nicardipine-retard in patients with essential hypertension. Jpn Pharmacol Ther. 1993;21:59-95. In Japanese.
5. Arakawa K, Iimura O, Onodera S, et al. Clinical evaluation of MPC-1304 on essential hypertension: A double-blind study comparing with nicardipine-retard. J Clin Ther Med. 1995;11:1503-1534. In Japanese.
6. Yoshinaga K, Abe K, Iimura O, et al. Clinical evaluation of benazepril HCl (CGS 14824A) monotherapy in essential hypertension: Double-blind comparative study with enalapril maleate. J Clin Ther Med. 1991;7:2525-2565. In Japanese.
7. Saruta T, Omae T, Kuramochi M, et al. Clinical usefulness of imidapril hydrochloride (ACE/TA-6366) in essential hypertension: A double-blind comparative study with enalapril maleate. J Clin Ther Med. 1992;8:661-697. In Japanese.
8. Yoshinaga K, Abe K, Iimura O, et al. Clinical evaluation of temocapril hydrochloride (CS-622), an angiotensin-converting enzyme inhibitor, used alone for treatment of essential hypertension: Results of double-blind enalapril maleate-controlled study. Clin Eval. 1992;20:11-44. In Japanese.
9. Arakawa K, Saruta T, Iimura O, et al. Clinical evaluation of angiotensin-converting enzyme inhibitor, trandolapril (RU 44570), in patients with essential hypertension: Multicentered double-blind comparative study with enalapril maleate. Clin Eval. 1992;20:477-511. In Japanese.
10. Kuramoto K, Fukiyama K, Iimura T, et al. Clinical evaluation of quinapril in patients with essential hypertension: A double-blind comparative study with enalapril maleate. J Clin Exp Med. 1994;169: 369-406. In Japanese.
11. Arakawa K, Kaneko Y, Iimura O, et al. Clinical efficacy of once-daily administration of bopindolol (LT 31-200) in patients with essential hypertension: A multicenter double-blind comparison study with atenolol. J Clin Exp Med. 1989;151: 705-733. In Japanese.
12. Goto Y, Ogihara T, Kumahara Y, et al. Clinical efficacy of carvedilol (DQ-2466) in patients with essential hypertension: A double-blind comparative study with labetalol. Jpn J Clin Exp Med. 1990;67: 211-236. In Japanese.
13. Yoshinaga K, Abe K, Kokubu T, et al. Clinical utility of betaxolol hydrochloride as monotherapy in essential hypertension: Double blind comparative study with slow-release propranolol hydrochloride. J Clin Ther Med. 1990;6:2657-2688. In Japanese.
14. Yoshinaga K, Ogihara T, Goto Y, et al. Clinical efficacy of carvedilol (DQ-2466) in patients with essential hypertension: A double-blind comparative study with nadolol. Jpn J Clin Exp Med. 1992;69: 243-267. In Japanese.
15. Arakawa K, Ishii M, Iimura O, et al. Clinical evaluation of bevantolol hydrochloride (NC-1400) as monotherapy for essential hypertension: Double-blind comparison with metoprolol tartrate. J Clin Ther Med. 1992;8:2147-2191. In Japanese.
16. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: Final results. JAMA. 1993;270:713-724.
17. Smolensky MH. Chronobiology and chronotherapeutics: Applications to cardiovascular medicine. Am J Hypertens. 1996;9(Part 3):11S-21S.
18. Uezono K. Chronopharmacology of anti-hypertensive drugs. Molec Med. 1997;34: 344-352. In Japanese.
19. Mensah GA. Research issues and ethnic implications in essential hypertension. J Assoc Acad Minor Phys. 1991;2:168-173.